Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating activities:
Net income (loss)	$ 26,132	$ (25,937)
Adjustments to net income (loss):
Provision for bad debts	233	145
Deferred tax expense	4,555	4,349
Depreciation and amortization	14,533	23,608
Amortization of debt discount and issuance costs	2,826	1,710
Equity-based compensation	3,366	4,508
Contingent consideration	1,338	(3,731)
Warranty provision	436	594
Write-down of inventories	1,847	409
Change in fair value of derivative assets	1,950	0
Changes in operating assets and liabilities, net of business acquisition
Accounts receivable	6,238	(44,268)
Inventories	(23,312)	(46,250)
Income tax receivables	369	(21,924)
Prepaid expenses and other	(6,947)	11,558
Accounts payable	30,155	59,419
Accrued expenses and other	3,900	7,027
Income tax payable	4,952	(8,760)
Lease liabilities	824	6,085
Deferred revenue	(27,579)	(18,639)
Net cash provided by (used in) operating activities	45,816	(50,097)
Investing activities:
Purchase of property, plant and equipment	(3,883)	(2,357)
Acquisition of STI, net of cash acquired	0	(373,816)
Net cash used in investing activities	(3,883)	(376,173)
Financing activities:
Proceeds from Series A issuance	0	33,098
Proceeds from common stock issuance	0	15,885
Series A equity issuance costs	(750)	(175)
Common stock issuance costs	0	(450)
Proceeds from revolving credit facility	0	52,000
Proceeds from issuance of other debt	6,469	6,229
Principal payments on term loan facility	(11,075)	(4,368)
Principal payments on other debt	(17,206)	0
Contingent consideration payments	(1,200)	(1,483)
Net cash provided by (used in) financing activities	(23,762)	100,736
Effect of exchange rate changes on cash and cash equivalent balances	(4,316)	7,355
Net change in cash and cash equivalents	13,855	(318,179)
Cash and cash equivalents, beginning of period	133,901	367,670
Cash and cash equivalents, end of period	147,756	49,491
Supplemental Cash Flow Information
Cash paid for interest	7,980	3,039
Cash paid for income taxes	2,522	0
Non-cash Investing and Financing Activities
Dividends accrued on Series A Preferred	6,350	6,189
Stock consideration paid for acquisition of STI	$ 0	$ 200,224